US recommends 'pause' for J&J vaccine over clot reports

WASHINGTON, D.C.: The United States is recommending a “pause” in administration of the single-dose Johnson & Johnson Covid-19 vaccine to investigate reports of potentially dangerous blood clots.

In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating unusual clots in six women that occurred 6 to 13 days after vaccination. The clots occurred in veins that drain blood from the brain and occurred together with low platelets. All six cases were in women between the ages of 18 and 48.